69 related articles for article (PubMed ID: 7726006)
1. Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase.
Turriziani O; Antonelli G; Jacobsen H; Mous J; Riva E; Pistello M; Dianzani F
Acta Virol; 1994 Oct; 38(5):297-8. PubMed ID: 7726006
[TBL] [Abstract][Full Text] [Related]
2. Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959.
Eberle J; Bechowsky B; Rose D; Hauser U; von der Helm K; Gürtler L; Nitschko H
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):671-6. PubMed ID: 7576926
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.
Jacobsen H; Yasargil K; Winslow DL; Craig JC; Kröhn A; Duncan IB; Mous J
Virology; 1995 Jan; 206(1):527-34. PubMed ID: 7831807
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors: drug resistance and cross resistance overview.
James JS
AIDS Treat News; 1995 Nov; (no 235):3-5. PubMed ID: 11363046
[TBL] [Abstract][Full Text] [Related]
5. In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies.
Jacobsen H; Hänggi M; Ott M; Duncan IB; Owen S; Andreoni M; Vella S; Mous J
J Infect Dis; 1996 Jun; 173(6):1379-87. PubMed ID: 8648209
[TBL] [Abstract][Full Text] [Related]
6. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
7. Saquinavir thwarts resistance.
AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir.
Côté HC; Brumme ZL; Harrigan PR
J Virol; 2001 Jan; 75(2):589-94. PubMed ID: 11134271
[TBL] [Abstract][Full Text] [Related]
9. Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials.
Jacobsen H; Haenggi M; Ott M; Duncan IB; Andreoni M; Vella S; Mous J
Antiviral Res; 1996 Jan; 29(1):95-7. PubMed ID: 8721556
[TBL] [Abstract][Full Text] [Related]
10. In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385.
Yates PJ; Hazen R; St Clair M; Boone L; Tisdale M; Elston RC
Antimicrob Agents Chemother; 2006 Mar; 50(3):1092-5. PubMed ID: 16495277
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
Rose RE; Gong YF; Greytok JA; Bechtold CM; Terry BJ; Robinson BS; Alam M; Colonno RJ; Lin PF
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1648-53. PubMed ID: 8643685
[TBL] [Abstract][Full Text] [Related]
12. Protease inhibitors and prevention of cross resistance.
Levin J
AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
[TBL] [Abstract][Full Text] [Related]
13. Conference looks at HIV drug resistance.
Chang HE
GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication.
Margerison ES; Maguire M; Pillay D; Cane P; Elston RC
J Antimicrob Chemother; 2008 Apr; 61(4):786-91. PubMed ID: 18252693
[TBL] [Abstract][Full Text] [Related]
15. Development of drug resistance to HIV-1 protease inhibitors.
Ridky T; Leis J
J Biol Chem; 1995 Dec; 270(50):29621-3. PubMed ID: 8530341
[No Abstract] [Full Text] [Related]
16. Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors.
Roberts NA
AIDS; 1995 Dec; 9 Suppl 2():27-S32. PubMed ID: 8775804
[TBL] [Abstract][Full Text] [Related]
17. Invirase and cross resistance.
AIDS Patient Care; 1995 Oct; 9(5):256. PubMed ID: 11361409
[No Abstract] [Full Text] [Related]
18. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
[TBL] [Abstract][Full Text] [Related]
19. Saquinavir: an HIV proteinase inhibitor.
Bragman K
Adv Exp Med Biol; 1996; 394():305-17. PubMed ID: 8815695
[No Abstract] [Full Text] [Related]
20. PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection study.
Dandache S; Coburn CA; Oliveira M; Allison TJ; Holloway MK; Wu JJ; Stranix BR; Panchal C; Wainberg MA; Vacca JP
J Med Virol; 2008 Dec; 80(12):2053-63. PubMed ID: 19040279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
